Oncolix Inc. (fka ONCX)

[dabullishbear]

Oncolix has already tested Prolanta on 3 patients which is also known as the first cohort. That has been confirmed and is not required to be updated on the clinical trial page. Results on that page are not to be updated until all cohorts of phase I have been completed and the results have been audited and peer reviewed. It has already been confirmed many many times that BioVectra is the contract manufacturer for Prolanta. And no it doesn't need to appear in an 8-K as that is not considered materially significant information. The PR stating that the drug was being shipped to the trial site from the contract manufacturer is enough to suffice.